Since 1990, helping busy clinicians master the science and art of caring for people with HIV disease.

PRN Member Menu

Due to the COVID-19 pandemic, all meetings are now via the Zoom Webinar platform.
Pre-Register Here
Please help PRN by taking the pre-meeting evaluation. These surveys are critical to the future of our programs and accreditation.
Pre-Meeting Survey
MEETING AND CME INFORMATION

PRN Meeting: August 17, 2022 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 6:30 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Course Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

Monkeypox Epidemic Outside of Endemic Regions: Experience from the UK & Europe

Sanjay R. Bhagani, MD

President, European AIDS Clinical Society (EACS)
Consultant Physician/Hon. Associate Professor
Department of Infectious Diseases/HIV Medicine
Royal Free Hospital and University College London, UK

Learning Objectives:

At the completion of this educational session, participants will:
1. Be able to describe the MPX epidemic amongst gay, bisexual and MSM communities in the UK.
2. Be aware of the clinical presentation and differential diagnosis of MPX.
3. Understand the natural history and management strategies.

Highlights from the 24th International AIDS Conference

W. David Hardy, MD, AAHIVS

Scientific and Medical Consultant
Adjunct Clinical Professor of Medicine
Division of Infectious Diseases
Keck School of Medicine of USC, Los Angeles

Learning Objectives:

At the completion of this educational session, participants will:
1. Be able to discuss new clinically relevant advances in antiretroviral therapy and prevention strategies for HIV.
2. Learn about new drugs for HIV treatment and prevention.
3. Recognize emerging adverse effects including metabolic effects associated with antiretrovirals used for treatment and prevention of HIV.

Accreditation Statement: This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). The Medical Society of the State of New York (MSSNY) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

As an ACCME-accredited provider, MSSNY is required to identify and mitigate relevant financial relationships of all individuals in control of CME content. Financial relationships are relevant if the following three conditions are met for the prospective person who will control content of the education: A financial relationship, in any amount, exists between the person in control of content and an ineligible company; The financial relationship existed during the past 24 months; The content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Dr. James F. Braun (Planner/Course Director/Moderator) has no relevant financial relationships to disclose. Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose. Dr. Thomas J. Hope (Presenter) has no relevant financial relationships to disclose. Dr. Hope submitted their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature. Dr. Martin Hoenigl (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research funding from Gilead, MSD, Scynexis, F2G, Euroimmune, Pfizer, Astellas, and Pulmocide. Dr. Hoenigl submitted their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

PRN Member Menu

Are you a member? If so, please log-in.

Not a member? Please register.

Have you forgotten your password?